SCHEMBL6601657

SCHEMBL6601657

COc1ccc(C2=NN(C(=O)c3cccc(NC(=O)c4cnccn4)c3)CCC2)cc1OC1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.47
PDE5A O76074 1/20 0.46
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE1C Q14123 1/20 0.46
PDE4D Q08499 9/20 0.45
PDE4A P27815 9/20 0.45
PDE4B Q07343 8/20 0.45
PDE4C Q08493 8/20 0.45
NPC1 O15118 1/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CFTR P13569 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6602109 0.93 RAB9A (0.53) RAB9ANPC1HPGDSMN1; SMN2LMNA
SCHEMBL6600681 0.92 PDE4D (0.47) PDE5APDE1APDE1BPDE1CPDE4D
SCHEMBL6600966 0.92 PDE4A (0.48) RAB9APDE5APDE1APDE1BPDE1C
SCHEMBL6601233 0.91 PDE5A (0.46) PDE5APDE1APDE1BPDE1CPDE4D
SCHEMBL145758 0.91 PDE5A (0.49) PDE5APDE1APDE1BPDE1CPDE4D
SCHEMBL6604386 0.89 RAB9A (0.51) RAB9ANPC1HPGDSMN1; SMN2LMNA
SCHEMBL6602086 0.89 PDE5A (0.49) PDE5APDE1APDE1BPDE1CPDE4D
SCHEMBL6605978 0.89 PDE5A (0.51) PDE5APDE1APDE1BPDE1CPDE4D
SCHEMBL6603487 0.87 PDE5A (0.46) PDE5APDE1APDE1BPDE1CPDE4D
SCHEMBL6602063 0.86 PDE4B (0.52) PDE5APDE1APDE1BPDE1CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
EP-1143944-A3 USE OF ARYLALKANOYLPYRIDAZINES MERCK PATENT GmbH (DE) 2002-09-11 EP disclosed
EP-1143944-A2 USE OF ARYLALKANOYLPYRIDAZINES MERCK PATENT GmbH (DE) 2001-10-17 EP disclosed
WO-2000059484-A2 USE OF ARYLALKANOYLPYRIDAZINES MERCK PATENT GMBH (DE) 2000-10-12 WO disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed
EP-0922036-A1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GmbH (DE) 1999-06-16 EP disclosed
WO-1998006704-A1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 1998-02-19 WO disclosed